Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced that Douglas A. Hamilton has been appointed President and Chief Executive Officer of the company.
SYNG Pharma Partners with Impact Centre to Develop Endometriosis Diagnostic
University of Waterloo Announces $400,000 AI Partnership with Manulife Financial
Cyclica Announces Collaboration with Eurofarma
Nanology Labs Wins Ontario Brain Institute Award
Therapure Biomanufacturing Announces FDA Approval for Manufacturing of Insmed’s ARIKAYCE®
Therapure Biomanufacturing announced approval for the manufacturing of partner Insmed’s ARIKAYCE® at its Mississauga facility by the U.S. FDA. ARIKAYCE is the first and only treatment approved by the FDA specifically for patients with Mycobacterium avium complex lung disease, a chronic and debilitating condition that can significantly increase patient morbidity and mortality.
Nobel Prize in Physiology or Medicine Recognizes Breakthrough Cancer Research
The 2018 Nobel Prize in Physiology or Medicine was awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”
Register Now for HealthTO October Edition, Oct 10
Apply now for H2i's Pitch Perfect Competition
Flosonics Medical Accepted into Lazaridis Scale-Up Program
Impact Centre Releases Report "The Land of Stranded Pilots"
BIOTECanada and Deloitte Release Results of Biotechnology Industry Data Survey
OBIO Expands ‘Access to Talent’ Programs, Announces OBIO Job Board - Free Service for Ontario's Health Science Industry
In response to industry demand, OBIO is proud to announce the launch of the OBIO Job Board, its latest ‘Access to Talent’ program.
The OBIO Job Board will be hosted on the newly revamped OBIO website and will be free for all health science companies wishing to post their latest health science job openings.
On Now: Global Biotech Week, Sept 24-30
Register Now for Upcoming Medventions Lectures
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
MaRS and University of Toronto Announce New Waterfront Tech Hub
Register Now for the Medicine by Design Symposium, Dec 4
Canada's Economic Strategy Tables Release Health and Biosciences Report
The report entitled “The Innovation and Competitiveness Imperative: Seizing Opportunities for Growth”, contains recommendations from six sectors with high growth potential, including the health and biosciences sector. The report outlined the roadmap to doubling the size of the health and biosciences sector and becoming a top-three global hub.